| Dr Mervat Basta, MD | |
|
4825 S Highway 95 # 2-356, Fort Mohave, AZ 86426 | |
| (888) 206-5902 | |
| (480) 466-7536 |
| Full Name | Dr Mervat Basta |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 43 Years |
| Location | 4825 S Highway 95 # 2-356, Fort Mohave, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285770115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 26169 (Arizona) | Secondary |
| 282N00000X | General Acute Care Hospital | 26169 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Havasu Regional Medical Center | Lake havasu city, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Services Of Arizona Pc | 6608247374 | 58 |
News Archive
Impax Laboratories, Inc. today reported adjusted net revenue in the third quarter of 2010, excluding the effect of a change in accounting for revenue received under the Company's Strategic Alliance Agreement with Teva, increased $42.6 million to $107.6 million compared to the prior year period, driven by sales of generic Adderall XR for which there were no sales in the third quarter of 2009, as well as increased sales of the Company's fenofibrate products.
Research from the Sidney Kimmel Cancer Center - Jefferson Health (SKCC) found significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.
Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver.
There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create.
› Verified 4 days ago
| Entity Name | Valley Anesthesiology Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285660704 PECOS PAC ID: 4880591841 Enrollment ID: O20031217000620 |
News Archive
Impax Laboratories, Inc. today reported adjusted net revenue in the third quarter of 2010, excluding the effect of a change in accounting for revenue received under the Company's Strategic Alliance Agreement with Teva, increased $42.6 million to $107.6 million compared to the prior year period, driven by sales of generic Adderall XR for which there were no sales in the third quarter of 2009, as well as increased sales of the Company's fenofibrate products.
Research from the Sidney Kimmel Cancer Center - Jefferson Health (SKCC) found significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.
Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver.
There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create.
› Verified 4 days ago
| Entity Name | Capstone Medical Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225436694 PECOS PAC ID: 5597081109 Enrollment ID: O20150225002119 |
News Archive
Impax Laboratories, Inc. today reported adjusted net revenue in the third quarter of 2010, excluding the effect of a change in accounting for revenue received under the Company's Strategic Alliance Agreement with Teva, increased $42.6 million to $107.6 million compared to the prior year period, driven by sales of generic Adderall XR for which there were no sales in the third quarter of 2009, as well as increased sales of the Company's fenofibrate products.
Research from the Sidney Kimmel Cancer Center - Jefferson Health (SKCC) found significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.
Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver.
There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create.
› Verified 4 days ago
| Entity Name | Anesthesia Services Of Arizona Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336857085 PECOS PAC ID: 6608247374 Enrollment ID: O20230118000286 |
News Archive
Impax Laboratories, Inc. today reported adjusted net revenue in the third quarter of 2010, excluding the effect of a change in accounting for revenue received under the Company's Strategic Alliance Agreement with Teva, increased $42.6 million to $107.6 million compared to the prior year period, driven by sales of generic Adderall XR for which there were no sales in the third quarter of 2009, as well as increased sales of the Company's fenofibrate products.
Research from the Sidney Kimmel Cancer Center - Jefferson Health (SKCC) found significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.
Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver.
There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mervat Basta, MD Po Box 52650, Mesa, AZ 85208-0133 Ph: (888) 206-5902 | Dr Mervat Basta, MD 4825 S Highway 95 # 2-356, Fort Mohave, AZ 86426 Ph: (888) 206-5902 |
News Archive
Impax Laboratories, Inc. today reported adjusted net revenue in the third quarter of 2010, excluding the effect of a change in accounting for revenue received under the Company's Strategic Alliance Agreement with Teva, increased $42.6 million to $107.6 million compared to the prior year period, driven by sales of generic Adderall XR for which there were no sales in the third quarter of 2009, as well as increased sales of the Company's fenofibrate products.
Research from the Sidney Kimmel Cancer Center - Jefferson Health (SKCC) found significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.
Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver.
There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create.
› Verified 4 days ago